These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1145 related articles for article (PubMed ID: 17597346)

  • 1. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit.
    Moore KH; Sweeney KJ; Wilson ME; Goldberg JI; Buchanan CL; Tan LK; Liberman L; Turner RR; Lagios MD; Cody Iii HS; Giuliano AE; Silverstein MJ; Van Zee KJ
    Ann Surg Oncol; 2007 Oct; 14(10):2911-7. PubMed ID: 17597346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ductal carcinoma in situ: value of sentinel lymph node biopsy.
    Sakr R; Barranger E; Antoine M; Prugnolle H; Daraï E; Uzan S
    J Surg Oncol; 2006 Oct; 94(5):426-30. PubMed ID: 16967457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel lymph node positivity of patients with ductal carcinoma in situ or microinvasive breast cancer.
    Katz A; Gage I; Evans S; Shaffer M; Fleury T; Smith FP; Flax R; Drogula C; Petrucci P; Magnant C
    Am J Surg; 2006 Jun; 191(6):761-6. PubMed ID: 16720145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy.
    Mittendorf EA; Arciero CA; Gutchell V; Hooke J; Shriver CD
    Curr Surg; 2005; 62(2):253-7. PubMed ID: 15796952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ.
    Dominguez FJ; Golshan M; Black DM; Hughes KS; Gadd MA; Christian R; Lesnikoski BA; Specht M; Michaelson J; Smith BL
    Ann Surg Oncol; 2008 Jan; 15(1):268-73. PubMed ID: 17891441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of sentinel lymph node biopsy in breast ductal carcinoma in situ upstaged to invasive carcinoma.
    Sakr R; Antoine M; Barranger E; Dubernard G; Salem C; Daraï E; Uzan S
    Breast J; 2008; 14(1):55-60. PubMed ID: 18186866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of patients with ductal carcinoma in situ and sentinel node biopsy.
    Meretoja TJ; Heikkilä PS; Salmenkivi K; Leidenius MH
    Ann Surg Oncol; 2012 Jul; 19(7):2345-51. PubMed ID: 22395995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel lymph node biopsy for localised ductal carcinoma in situ?
    Veronesi P; Intra M; Vento AR; Naninato P; Caldarella P; Paganelli G; Viale G
    Breast; 2005 Dec; 14(6):520-2. PubMed ID: 16185871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of invasion and axillary lymph node metastasis in patients with a core biopsy diagnosis of ductal carcinoma in situ: an analysis of 255 cases.
    Han JS; Molberg KH; Sarode V
    Breast J; 2011; 17(3):223-9. PubMed ID: 21545433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An update of sentinel lymph node mapping in patients with ductal carcinoma in situ.
    Wilkie C; White L; Dupont E; Cantor A; Cox CE
    Am J Surg; 2005 Oct; 190(4):563-6. PubMed ID: 16164920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
    Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
    Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ductal carcinoma in situ of the breast with microinvasion. Role of sentinel lymph node biopsy].
    Le Bouëdec G; de Lapasse C; Mishellany F; Chêne G; Michy T; Gimbergues P; Dauplat J
    Gynecol Obstet Fertil; 2007 Apr; 35(4):317-22. PubMed ID: 17344087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS?
    Cox CE; Nguyen K; Gray RJ; Salud C; Ku NN; Dupont E; Hutson L; Peltz E; Whitehead G; Reintgen D; Cantor A
    Am Surg; 2001 Jun; 67(6):513-9; discussion 519-21. PubMed ID: 11409797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.
    Langer I; Guller U; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
    Ann Surg Oncol; 2009 Dec; 16(12):3366-74. PubMed ID: 19760047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study.
    Reed J; Rosman M; Verbanac KM; Mannie A; Cheng Z; Tafra L
    J Am Coll Surg; 2009 Mar; 208(3):333-40. PubMed ID: 19317993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relevance of occult axillary micrometastasis in ductal carcinoma in situ: a clinicopathologic study with long-term follow-up.
    Lara JF; Young SM; Velilla RE; Santoro EJ; Templeton SF
    Cancer; 2003 Nov; 98(10):2105-13. PubMed ID: 14601079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases.
    Goyal A; Douglas-Jones A; Monypenny I; Sweetland H; Stevens G; Mansel RE
    Breast Cancer Res Treat; 2006 Aug; 98(3):311-4. PubMed ID: 16552627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of sentinel lymph node biopsy in high-risk ductal carcinoma in situ patients.
    Moran CJ; Kell MR; Flanagan FL; Kennedy M; Gorey TF; Kerin MJ
    Am J Surg; 2007 Aug; 194(2):172-5. PubMed ID: 17618799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel lymph node metastasis from mammary ductal carcinoma in situ with microinvasion.
    Zavagno G; Belardinelli V; Marconato R; Carcoforo P; Franchini Z; Scalco G; Burelli P; Pietrarota P; Mencarelli R; Marconato G; Nitti D
    Breast; 2007 Apr; 16(2):146-51. PubMed ID: 17046258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erratum to: Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up.
    Kiluk JV; Ly QP; Santillan AA; Meade T; Ramos D; Reintgen DS; Dessureault S; Davis M; Shamehdi C; Cox CE
    Ann Surg Oncol; 2010 Feb; 17(2):552-7. PubMed ID: 19957043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.